AR-13503 | m-entrepreneurship.com

Product Name :
AR-13503

Search keywords :
AR-13503

drugId :
null

Target Vo:
Protein kinase C

Target Vo Short Name :
PKC

Moa_Name:
Protein kinase C inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aerie Pharmaceuticals Inc

Active Company_Name :
Aerie Pharmaceuticals Inc

Active Indication_Name:
Macular Degeneration

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Aurora A Antibody
Keap1 Antibody
xCT Antibody (YA006): xCT Antibody (YA006) is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to xCT. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts